PRADAXA 75MG CAPSULES contain Dabigatran Etexilate 75mg, an oral anticoagulant that helps prevent blood clot formation and is prescribed for specific clot-related conditions under medical supervision.
PRADAXA 75MG CAPSULES | Dabigatran Etexilate Anticoagulant Guide
PRADAXA 75MG CAPSULES contain Dabigatran Etexilate 75mg, an oral anticoagulant that helps prevent blood clot formation and is prescribed for specific clot-related conditions under medical supervision.
PRADAXA 75MG CAPSULES
PRADAXA 75MG CAPSULES (DABIGATRAN ETEXILATE 75MG): Comprehensive Guide and Benefits
Introduction to PRADAXA 75MG CAPSULES
PRADAXA 75MG: Direct Oral Anticoagulant Therapy
PRADAXA 75MG CAPSULES contain Dabigatran Etexilate 75mg, an oral anticoagulant belonging to the Direct Thrombin Inhibitor (DTI) class. It is a prescription medicine used to reduce the formation of harmful blood clots in selected patients according to their medical condition and risk factors.
Dabigatran works by blocking thrombin, an enzyme involved in blood clot formation. By reducing thrombin activity, PRADAXA helps prevent abnormal clot development while maintaining controlled blood coagulation. PRADAXA 75MG CAPSULES should only be used under the guidance of a qualified healthcare professional due to bleeding risks associated with anticoagulant therapy.
Key Benefits of PRADAXA 75MG CAPSULES
Helps reduce the risk of unwanted blood clot formation.
Supports prevention of clot-related complications in suitable patients.
Helps reduce the risk of stroke and systemic embolism in certain patients with non-valvular atrial fibrillation when prescribed appropriately.
May be used for prevention of venous thromboembolic events after certain orthopedic surgeries as indicated.
Provides an oral alternative to traditional anticoagulant therapies.
How PRADAXA 75MG CAPSULES Works
PRADAXA contains Dabigatran Etexilate, which is converted in the body into its active form, Dabigatran.
Dabigatran directly inhibits thrombin (Factor IIa), an important enzyme responsible for converting fibrinogen into fibrin during clot formation.
By blocking thrombin activity, PRADAXA reduces the ability of blood to form clots, helping prevent dangerous clot-related events.
Usage Instructions for PRADAXA 75MG CAPSULES
Take PRADAXA 75MG CAPSULES exactly as prescribed by your doctor.
Swallow the capsule whole with water.
Do not open, crush, or chew the capsule.
Take doses at the recommended time intervals.
Do not stop treatment suddenly without medical advice, as stopping anticoagulant therapy may increase clotting risk.
Inform your doctor before any surgery, dental procedure, or invasive treatment.
Medicinal Advantages of PRADAXA 75MG CAPSULES
Provides effective anticoagulation through direct thrombin inhibition.
Helps prevent formation of harmful blood clots.
Does not require routine INR monitoring like warfarin therapy.
Offers predictable anticoagulant activity when used at the prescribed dose.
Supports management of clotting risks in carefully selected patients.
Note: PRADAXA is a prescription anticoagulant. The dose is selected based on the patient’s condition, kidney function, age, and bleeding risk.
Off-Label Uses of PRADAXA 75MG CAPSULES
Dabigatran may be considered for additional clinical situations by specialists based on available evidence and individual patient requirements.
Possible specialist-guided applications may include:
Individualized anticoagulation strategies.
Management of specific thromboembolic risks.
Disclaimer: Off-label use should only be undertaken under specialist medical supervision.
Expert Advice for Optimal Use
Take PRADAXA exactly as prescribed.
Avoid missing doses.
Inform all healthcare providers that you are taking an anticoagulant.
Avoid activities that increase the risk of injury or bleeding.
Report unusual bleeding, black stools, blood in urine, or unexplained bruising.
Regular kidney function assessment may be recommended.
Precautions
Bleeding Risk
Because PRADAXA reduces blood clot formation, it may increase the risk of bleeding. Seek medical advice if unusual or prolonged bleeding occurs.
Kidney Function
Dabigatran is eliminated mainly through the kidneys. Patients with kidney problems may require dose adjustment or closer monitoring.
Pregnancy & Breastfeeding
Consult your doctor before using PRADAXA during pregnancy or breastfeeding.
Drug Interactions
Inform your doctor if you use:
Other anticoagulants or blood thinners
Antiplatelet medicines
NSAID painkillers
Certain antifungal medicines
Certain antibiotics
Heart rhythm medicines
Existing Medical Conditions
Tell your doctor if you have:
Kidney disease
Active bleeding
History of stomach ulcers
Liver problems
Recent surgery or planned procedures
Storage Instructions
Store PRADAXA capsules according to the instructions on the product label.
Keep capsules in the original packaging.
Protect from moisture.
Keep away from children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is PRADAXA 75MG CAPSULES used for?
A: PRADAXA 75MG CAPSULES are used as an anticoagulant to help prevent and manage certain blood clot-related conditions under medical supervision.
Q: What is the active ingredient in PRADAXA 75MG?
A: The active ingredient is Dabigatran Etexilate 75mg, a direct thrombin inhibitor anticoagulant.
Q: Is PRADAXA a blood thinner?
A: Yes. PRADAXA is commonly described as a blood thinner because it reduces the blood’s ability to form clots.
Q: Can PRADAXA 75MG be stopped suddenly?
A: Do not stop PRADAXA without consulting your doctor, as stopping anticoagulation without appropriate guidance may increase clotting risk.
Q: What are common side effects of PRADAXA?
A: Possible side effects may include bleeding, bruising, indigestion, stomach discomfort, and nausea. Serious bleeding requires immediate medical attention.
Q: Does PRADAXA require INR monitoring?
A: Unlike warfarin, PRADAXA generally does not require routine INR monitoring; however, kidney function and overall treatment response may need evaluation.
Product Tags
PRADAXA 75MG CAPSULES, Dabigatran Etexilate 75mg, Dabigatran Capsule, Direct Thrombin Inhibitor, Oral Anticoagulant Medicine, Blood Thinner Capsule, Stroke Prevention Medicine, Blood Clot Prevention Therapy, DVT Prevention Medicine, Antithrombotic Agent, Prescription Anticoagulant, Boehringer Ingelheim PRADAXA, PRADAXA Capsule, Cardiovascular Medicine, Thrombosis Management Therapy.
Happy Customer
Satnam Pharmaceuticals is a trusted medicine supply company committed to delivering high-quality healthcare products to pharmacies, hospitals, clinics, and healthcare providers. We offer a wide range of pharmaceutical medicines and healthcare essentials from reliable manufacturers.
Copyright © 2026 Satnam Pharma. All Rights Reserved.